Accès aux produits antipaludiques

SMS for Life

AMFm

CTAs

Moustiquaires et insecticides

Tests de diagnostic rapide

Groupe de Travail PSMWG

Rapports sur les CTAs et MILDAs

Documents de référence:

Proceedings of the Meeting on Public and Private Antimalarial Markets and Policy Surveys
September 2009 [in English]

Directives de l'OMS:

WHO informal consultation with manufacturers of artemisininbased pharmaceutical products in use for the treatment of malaria
WHO
August 2007 [in English]

Guidelines for the treatment of malariaGuidelines for the treatment of malaria
WHO
2010 [in English]
Updates as of April 2011

WHO AFRO RecommendationsRecommen- dations on the use of Sulfadoxine - Pyrimethamine (SP) for Intermittent Preventive Treatment during Pregnancy (IPT) in areas of moderate to high resistance to SP in the African Region
WHO AFRO
October 2005 [in English]

Implementation GuideChanging Malaria Treatment Policy to Artemisinin-Based Combinations
An Implementation Guide
December 2005 Acrobat logo [in English] [in French] [in Portuguese]

Version anglaise

Les Combinaisons Thérapeutiques à base d'Artémisinine (ACTs ou CTAs)

ACTs
Photo by Bonnie Gillespie, Johns Hopkins University

Les Combinaisons Thérapeutiques à base d'Artémisinine (ACTs ou CTAs) ci-dessous sont recommandées par l'OMS pour le traitement du paludisme provoqué par P. falciparum (en ordre alphabétique):

  1. artemether-lumefantrine,
  2. artesunate + amodiaquine,
  3. artesunate + mefloquine,
  4. artesunate + sulfadoxine–pyrimethamine,
  5. dihydroartemisinin + piperaquine,
  6. artesunate + pyronaridine tetraphosphate.

Liens et ressources:

  1. NewRBM‐WHO Round Table on ACT Supply, Geneva, 8th September: Meeting report
  2. Compilation of past and planned procurement of Artemisininbased Combination Therapies (ACTs) from available public sources
  3. ACTWatch includes Malaria drug database online
  4. Request for Expression of Interest (EOI) from ACTs manufacturers
  5. Prequalification Programme
  6. Prequalified Antimalarial Drugs
    Suppliers whose artemisinin-based combination antimalarial medicines have been found acceptable, in principle, for procurement by UN agencies
  7. Antimalarial Medicines (currently available for procurement by WHO)
  8. WHO malaria treatment policies
  9. CNAP Artemisia Research Project updates
  10. Active Pharmaceutical Ingredient Requirements for the manufacture of ACTs
    Position paper of the RBM Procurement and Supply Management Working Group

Evènements associés:

  1. 2011 Artemisinin Conference Hanoi, 2-3 November 2011
  2. RBM‐WHO Round Table on ACT Supply Geneva, 8 September 2011

Responsibly improving access to ACTs in the private sector

Report of the MoH (Uganda)-MMV Workshop Series

 

Pharmacovigilance resources

  1. Guidance document on pharmacovigilance for countries participating in AMFm Phase 1
  2. Including Pharmacovigilance in Global Fund's Round 8 Proposal [en français]
  3. Budgeting and Timeline for Establishing Pharmacovigilance Capacity
  4. Steps for Completing Global Fund's Round 8 Proposal for Requesting funds for Pharmacovigilance
  5. Steps for Accessing Funding from Global Fund for Pharmacovigilance for Ongoing grants: Midway or during start of Phase 2